Dmitry A. Serpukhovitin – Managing Manager for process Management Development of PJSC «Promsvyazbank» (Moscow, Russia). E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Pavel P. Topchy – Deputy General Director of the LLC «Komupak» (Moscow, Russia). E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Diana R. Nazyrova – Appraiser Assistant of the LLC «Dominant Service», Candidate of Economic Sciences (Novorossiysk, Russia). E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

The general characteristics of the instruments of state support of innovative activity of enterprises are given. Based on the rating of the most successful innovative enterprises in 2017–2020. a decrease in the share of pharmaceutical companies was established. The assessment of the credit and tax burden of pharmaceutical industry enterprises showed the need to improve the tools of state support for innovative pharmaceutical industry enterprises, including in order to reduce the credit and tax burden.

Key words: innovation, government support instruments, pharmaceutical industry, credit burden, tax burden.

JEL-codes: H5, H7.